Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Myomo, Inc. (MYO : AMEX)
 
 • Company Description   
Myomo, Inc. is a commercial stage medical robotics company. It offers expanded mobility which suffering from neurological disorders and upper limb paralysis. The company develops and markets the MyoPro(R) product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals. Myomo, Inc. is headquartered in Cambridge,Massachusetts.

Number of Employees: 93

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.55 Daily Weekly Monthly
20 Day Moving Average: 32,417 shares
Shares Outstanding: 6.88 (millions)
Market Capitalization: $17.53 (millions)
Beta: 1.06
52 Week High: $14.35
52 Week Low: $2.28
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -31.27% -24.97%
12 Week -65.63% -62.86%
Year To Date -62.75% -55.87%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
137 Portland St. 4th Floor
-
Boston,MA 02114
USA
ph: 617-996-9058
fax: -
ir@myomo.com http://www.myomo.com
 
 • General Corporate Information   
Officers
Paul R. Gudonis - Chief Executive Officer and Chairman
David A. Henry - Chief Financial Officer
Amy Knapp - Director
Thomas A. Crowley, Jr. - Director
Thomas F. Kirk - Director

Peer Information
Myomo, Inc. (BJCT)
Myomo, Inc. (CADMQ)
Myomo, Inc. (APNO)
Myomo, Inc. (UPDC)
Myomo, Inc. (IMTIQ)
Myomo, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 62857J201
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 6.88
Most Recent Split Date: 1.00 (0.03:1)
Beta: 1.06
Market Capitalization: $17.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.36 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.43 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 25.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.36
Price/Cash Flow: -
Price / Sales: 1.14
EPS Growth
vs. Year Ago Period: 28.07%
vs. Previous Quarter: 21.15%
Sales Growth
vs. Year Ago Period: 65.51%
vs. Previous Quarter: -4.07%
ROE
03/31/22 - -74.05
12/31/21 - -71.00
09/30/21 - -68.34
ROA
03/31/22 - -55.85
12/31/21 - -54.46
09/30/21 - -52.69
Current Ratio
03/31/22 - 3.57
12/31/21 - 4.48
09/30/21 - 4.42
Quick Ratio
03/31/22 - 3.35
12/31/21 - 4.29
09/30/21 - 4.25
Operating Margin
03/31/22 - -66.45
12/31/21 - -74.85
09/30/21 - -68.50
Net Margin
03/31/22 - -66.45
12/31/21 - -74.85
09/30/21 - -68.58
Pre-Tax Margin
03/31/22 - -65.56
12/31/21 - -74.21
09/30/21 - -68.12
Book Value
03/31/22 - 1.87
12/31/21 - 2.25
09/30/21 - 2.29
Inventory Turnover
03/31/22 - 5.25
12/31/21 - 4.76
09/30/21 - 5.07
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©